After a tumultuous tenure marked…
After a tumultuous tenure marked by recent clashes with the [...]
After a tumultuous tenure marked by recent clashes with the [...]
Under the deal with Lone Star Funds, Lonza maintains a [...]
Sen. Ron Wyden of Oregon is going straight to drugmakers [...]
Sanofi has agreed to sell its Medley generics unit in [...]
Almost all of last month’s top 10 pharma TV ad [...]
The three-pronged plan to strengthen domestic drug supply will be [...]
The FDA is ending a roughly nine-month hiatus of drug-related [...]
Less than two weeks after Pfizer struck a deal with [...]
Servier on Friday unveiled a deal to acquire Day One [...]
Kyowa Kirin has decided to discontinue all clinical development of [...]